CI vs. DXCM: Cigna vs. DexCom Stock Comparison
How do Cigna (CI) and DexCom (DXCM) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Cigna (CI) and DexCom (DXCM) both fall under the Health Care Equipment & Services industry group, but CI is classified in Health Care Providers & Services while DXCM is classified in Health Care Equipment & Supplies.
| Profile Item | CI | DXCM |
|---|---|---|
| Name | The Cigna Group | DexCom Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Services | Health Care Equipment |
| Market Capitalization | 77.36 billion USD | 29.62 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | March 31, 1982 | April 14, 2005 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | CI | DXCM |
|---|---|---|
| Total Return (1Y) | 13.95% | 46.33% |
| Total Return (3Y, Annualized) | 2.65% | -4.50% |
| Total Return (5Y, Annualized) | 8.40% | -12.76% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
DexCom (DXCM) has an aggressive beta of 1.43, indicating higher sensitivity to broad-market moves, while Cigna (CI) is defensive at 0.24 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.
| Metric | CI | DXCM |
|---|---|---|
| Volatility (1Y, Annualized) | 26.82% | 38.37% |
| Beta (5Y) | 0.24 | 1.43 |
| Max Drawdown (5Y) | -32.10% | -66.32% |
| Avg. Volume (3M) | 1.55M | 4.34M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | CI | DXCM |
|---|---|---|
| Sharpe Ratio (1Y) | 0.36 | 1.10 |
| Sortino Ratio (1Y) | 0.54 | 1.79 |
Profitability
ROE (TTM)
Both Cigna (CI) at 15.65% and DexCom (DXCM) at 37.67% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.
CI
Health Care Equipment & Services industry group
15.65%
- Max
- 47.61%
- CI
- 15.65%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
DXCM
Health Care Equipment & Services industry group
37.67%
- Max
- 47.61%
- DXCM
- 37.67%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
DexCom (DXCM) at 19.42% retains a top-quartile share of revenue as profit, ahead of Cigna (CI) at 2.09%, which keeps about the industry-typical share.
CI
Health Care Equipment & Services industry group
2.09%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- CI
- 2.09%
- Q1
- -6.29%
- Min
- -28.46%
DXCM
Health Care Equipment & Services industry group
19.42%
- Max
- 29.35%
- DXCM
- 19.42%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
DexCom (DXCM) at 24.34% operates in the top operating margin quartile, ahead of Cigna (CI) at 3.48%, which runs around its industry’s norm.
CI
Health Care Equipment & Services industry group
3.48%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- CI
- 3.48%
- Q1
- -0.28%
- Min
- -16.29%
DXCM
Health Care Equipment & Services industry group
24.34%
- Max
- 35.43%
- DXCM
- 24.34%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | CI | DXCM |
|---|---|---|
| ROE (TTM) | 15.65% | 37.67% |
| ROA (TTM) | 4.29% | 11.14% |
| Net Margin (TTM) | 2.09% | 19.42% |
| Operating Margin (TTM) | 3.48% | 24.34% |
| Gross Margin (TTM) | 9.09% | 63.42% |
Growth
Revenue Growth
Both Cigna (CI) at 11.26% and DexCom (DXCM) at 15.60% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Both Cigna (CI) at 83.00% and DexCom (DXCM) at 47.18% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.
Growth Metrics
| Metric | CI | DXCM |
|---|---|---|
| Revenue Growth (YoY) | 11.26% | 15.60% |
| Revenue Growth (3Y CAGR) | 15.15% | 17.01% |
| EPS Growth (YoY) | 83.00% | 47.18% |
| EPS Growth (3Y CAGR) | 1.36% | 36.60% |
Financial Strength
Current Ratio (MRQ)
DexCom (DXCM) at 1.74 keeps current ratio within its industry’s typical mid-range, while Cigna (CI) at 0.84 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for CI.
CI
Health Care Equipment & Services industry group
0.84
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- CI
- 0.84
- Min
- 0.30
DXCM
Health Care Equipment & Services industry group
1.74
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DXCM
- 1.74
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Cigna (CI) at 0.71 and DexCom (DXCM) at 0.55 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
CI
Health Care Equipment & Services industry group
0.71
- Max
- 1.88
- Q3
- 0.91
- CI
- 0.71
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
DXCM
Health Care Equipment & Services industry group
0.55
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- DXCM
- 0.55
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | CI | DXCM |
|---|---|---|
| Current Ratio (MRQ) | 0.84 | 1.74 |
| Debt / Equity (MRQ) | 0.71 | 0.55 |
| Net Debt / EBITDA | 1.87 | -0.28 |
Dividends
Dividend Yield (TTM)
DexCom (DXCM) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cigna (CI) reports a yield of 2.05%, ranking against industry peers normally.
CI
Health Care Equipment & Services industry group
2.05%
- CI
- 2.05%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
DexCom (DXCM) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cigna (CI) reports a payout of 27.29%, ranking against industry peers normally.
CI
Health Care Equipment & Services industry group
27.29%
- CI
- 27.29%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DXCM
Health Care Equipment & Services industry group
0.00%
- DXCM
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | CI | DXCM |
|---|---|---|
| Dividend Yield (TTM) | 2.05% | 0.00% |
| Dividend Payout Ratio (TTM) | 27.29% | 0.00% |
Valuation
P/E Ratio (TTM)
Cigna (CI) at 12.94 sits in the cheaper P/E ratio quartile, while DexCom (DXCM) at 31.26 is closer to its industry’s usual earnings multiple — a discount for CI, though growth and earnings durability still matter.
CI
Health Care Equipment & Services industry group
12.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- CI
- 12.94
- Min
- 4.21
DXCM
Health Care Equipment & Services industry group
31.26
- Max
- 80.41
- Q3
- 47.62
- DXCM
- 31.26
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Cigna (CI) at 0.27 looks cheap on sales in the lower P/S ratio quartile, while DexCom (DXCM) at 5.80 looks rich in the upper quartile — a clear gap in price per dollar of revenue.
CI
Health Care Equipment & Services industry group
0.27
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- CI
- 0.27
- Min
- 0.03
DXCM
Health Care Equipment & Services industry group
5.80
- Max
- 8.80
- DXCM
- 5.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Cigna (CI) at 1.79 is valued about in line with its industry on P/B ratio, while DexCom (DXCM) at 11.68 carries an above-peer premium to book — DXCM is pricier on assets.
CI
Health Care Equipment & Services industry group
1.79
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- CI
- 1.79
- Q1
- 1.73
- Min
- -1.31
DXCM
Health Care Equipment & Services industry group
11.68
- DXCM
- 11.68
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | CI | DXCM |
|---|---|---|
| P/E Ratio (TTM) | 12.94 | 31.26 |
| P/S Ratio (TTM) | 0.27 | 5.80 |
| P/B Ratio (MRQ) | 1.79 | 11.68 |
| Free Cash Flow Yield (TTM) | 10.59% | 2.74% |